论文部分内容阅读
目的:分析并探讨孟鲁司特钠联合布地奈德治疗小儿支气管哮喘的临床疗效观察。方法:选取2012年1月~2014年1月期间来我院进行治疗的小儿支气管哮喘患者140例,随机分为两组,每组70例,分别为观察组与对照组。观察组给予孟鲁司特钠联合布地奈德治疗,对照组则仅给予布地奈德进行治疗,观察两组治疗效果。结果:观察组患者显效35例,有效31例,无效4例,有效率为94.29%;对照组显效28例,有效31例,无效11例,有效率为84.29%。结论:孟鲁司特钠联合布地奈德治疗小儿支气管哮喘临床疗效显著,值得推广。
Objective: To analyze and discuss the clinical efficacy of montelukast combined with budesonide in the treatment of pediatric bronchial asthma. Methods: One hundred and fourteen children with bronchial asthma who were treated in our hospital from January 2012 to January 2014 were randomly divided into two groups, 70 cases in each group, which were observation group and control group respectively. The observation group was treated with montelukast sodium and budesonide, while the control group was treated with budesonide only. The therapeutic effect was observed in both groups. Results: In the observation group, 35 cases were markedly effective, 31 cases were effective, 4 cases were ineffective, and the effective rate was 94.29%. In the control group, 28 cases were markedly effective, 31 cases were effective and 11 cases were ineffective. The effective rate was 84.29%. Conclusion: Montelukast combined with budesonide in children with bronchial asthma clinical significant effect, it is worth promoting.